Form 4: Elanco Animal Health: Insider Stock Unit Transaction

Jeffrey N. Simmons, CEO of Elanco Animal Health, reported a transaction involving deferred stock units on May 29, 2026.

Summary

• Jeffrey N. Simmons, President, CEO, and Director of Elanco Animal Health Inc., engaged in a transaction involving deferred stock units.
• The transaction, dated May 29, 2026, involved the acquisition of 118.5296 deferred stock units.
• These units are convertible into shares of Elanco Animal Health common stock or their cash equivalent.
• The settlement of these units is contingent upon termination of employment or a specified future year, as per the Executive Deferral and Stock Match Plan.
• The filing also includes a Power of Attorney granted by Jeffrey N. Simmons on May 21, 2026, authorizing specific individuals to act on his behalf for SEC filings.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral filing, as it represents a routine insider transaction related to executive compensation rather than a significant strategic or financial event.

Positives

• Insider participation in company stock plans can indicate confidence in future performance.
• The transaction involves deferred stock units, suggesting a long-term incentive structure for management.

Negatives

• The filing does not provide details on the acquisition price or the specific reason for the transaction, only that it was an acquisition of units.

Risks

• The value of the deferred stock units is subject to fluctuations in the company's stock price.
• Settlement is tied to employment termination or future dates, introducing timing-related uncertainties.

Future Outlook

The future outlook for the deferred stock units depends on the company's stock performance and the terms of the Executive Deferral and Stock Match Plan regarding settlement upon termination of employment or a specified future year.

Management Comments

• "Each deferred stock unit represents the right to receive one share of Company common stock or the cash equivalent."
• "Deferred stock units settle in cash or shares of Company common stock following termination of employment or during a specified future year in accordance with Executive Deferral and Stock Match Plan."

Industry Context

StockSavvy.ai notes that insider transactions involving stock units are common in the animal health industry as a means to align executive interests with shareholder value over the long term.

Corporate Governance

Stakeholder Impact

• Shareholders: The transaction itself does not directly impact share price but reflects management's long-term incentive alignment.
• Employees: The Executive Deferral and Stock Match Plan is a component of executive compensation, indirectly affecting employee morale and retention strategies.
• Management: Jeffrey N. Simmons's compensation is tied to company performance through these stock units.

Next Steps

• Settlement of deferred stock units upon termination of employment or in a specified future year.
• Continued compliance with Section 16 reporting requirements for future transactions.

Key Dates

Keywords

Elanco Animal Health, ELAN, Form 4, Insider Trading, Deferred Stock Units, Executive Compensation, SEC Filing, Securities Exchange Act, Jeffrey N. Simmons